Cargando…

Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study

BACKGROUND AND AIMS: In patients with chronic liver diseases (CLD) with or without cirrhosis, existing data on the risk of adverse outcomes with SARS-CoV-2 infection have been mixed or have limited generalizability. We used the National COVID Cohort Collaborative (N3C) Data Enclave, a harmonized ele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Jin, Pletcher, Mark J., Lai, Jennifer C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202438/ https://www.ncbi.nlm.nih.gov/pubmed/34127981 http://dx.doi.org/10.1101/2021.06.03.21258312

Ejemplares similares

Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
por: Ge, Jin, et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study
por: Ge, Jin, et al.
Publicado: (2022)

Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection
por: Wong, Robert J., et al.
Publicado: (2023)

487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis
por: Saunders-Hao, Patricia, et al.
Publicado: (2021)

Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis
por: Xiao, Yong, et al.
Publicado: (2020)

Unreported SARS-CoV-2 Home Testing and Test Positivity
por: Park, Soo, et al.
Publicado: (2023)

SARS-CoV-2 in patients with chronic liver disease
por: Hindson, Jordan
Publicado: (2020)

Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 Infection
por: Aung, Sidney, et al.
Publicado: (2021)

Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis
por: Matsuoka, Shunichi, et al.
Publicado: (2009)

Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
por: Kaewdech, Apichat, et al.
Publicado: (2022)

SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
por: Luxenburger, Hendrik, et al.
Publicado: (2023)

Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis
por: Cao, Huanhuan, et al.
Publicado: (2023)

Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis
por: Ihlow, Jana, et al.
Publicado: (2021)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
por: Moon, Andrew M., et al.
Publicado: (2020)

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
por: Ruether, Darius F., et al.
Publicado: (2022)

Durability of immune response to SARS-CoV-2 vaccination in patients with liver cirrhosis (LC) as compared to healthcare workers (HW)
por: Mangia, Alessandra, et al.
Publicado: (2022)

SARS-CoV-2 Infection and the Liver
por: Morgan, Katie, et al.
Publicado: (2020)

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
por: Alharbi, Sultan Nafea, et al.
Publicado: (2021)

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
por: Marjot, Thomas, et al.
Publicado: (2021)

Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
por: Nevola, Riccardo, et al.
Publicado: (2023)

Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
por: Mendizabal, Manuel, et al.
Publicado: (2021)

Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak
por: Piano, Salvatore, et al.
Publicado: (2021)

Increased Hepatic Expression of SARS-CoV-2 Entry Points and Proinflammatory Cytokines in Cirrhosis
por: Limon-De La Rosa, Nathaly, et al.
Publicado: (2022)

Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection
por: Zou, Xiaojing, et al.
Publicado: (2021)

Safety and Efficacy of SARS-CoV-2 Vaccination in Patients with Chronic Liver Disease
por: Mao, Yu-Feng, et al.
Publicado: (2023)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Liver dysfunction and SARS-CoV-2 infection
por: Gracia-Ramos, Abraham Edgar, et al.
Publicado: (2021)

SARS-CoV-2 infection and liver involvement
por: Luo, Mingjia, et al.
Publicado: (2022)

Effect of SARS-CoV-2 infection on the liver
por: Sanyaolu, Adekunle, et al.
Publicado: (2023)

Autoimmune liver diseases and SARS-CoV-2
por: Sgamato, Costantino, et al.
Publicado: (2023)

SARS‐CoV‐2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections
por: Reddy, K. Rajender
Publicado: (2020)

Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2
por: García-Gutiérrez, Ponciano, et al.
Publicado: (2021)

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
por: Baldelli, Luke, et al.
Publicado: (2023)

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
por: Wang, Jitao, et al.
Publicado: (2022)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Poor Response to Inactivated SARS-CoV-2 Vaccine in Patients With Chronic Liver Disease
por: Cao, Huanhuan, et al.
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mt5tupqdvh5tokk28io1ntos2n